Summary The objective of this study was first to determine whether three slowly growing early-generation murine transplantable tumours, the T40 fibrosarcoma, Ti 15 mammary carcinoma and T237 lung carcinoma, exhibit patterns of energetics and blood flow during growth that are different from those of the faster growing RIF-1 fibrosarcoma. Serial measurements were made with 31P-magnetic resonance spectroscopy (MRS), relating to nutritive blood flow and 2H-magnetic resonance imaging (MRI), which is sensitive to both nutritive and largevessel (non-nutritive) flow. All four tumour lines showed a decrease in fiNTP/Pi and pH with growth; however, each line showed a different pattern of blood flow that did not correlate with the decrease in energetics. Qualitative histological analysis strongly correlated with the 2H-MRI. Second, their response to 5 mg kg-' hydralazine i.v. was monitored by 31P-MRS. A marked decrease in f3NTP/Pi and pH was observed in both the RIF-1 fibrosarcoma and the third-generation T115 mammary carcinoma after hydralazine challenge. In contrast, the fourth generation T40 fibrosarcoma and T237 lung carcinoma showed no change in 31P-MRS parameters. However, a fifth-generation T237 cohort, which grew approximately three times faster than fourth-generation T237 cohorts, exhibited a significant deterioration in PNTP/Pi and pH in response to hydralazine. These data are consistent with a decoupling between large-vessel and nutritive blood flow and indicate that earlygeneration transplants that have a slow growth rate and vascular tone are more appropriate models of human tumour vasculature than more rapidly growing, repeatedly transplanted tumours.
Tumour blood flow is essential for the growth and development of cancers and can influence the outcome of most forms of nonsurgical therapies. A tumour obtains its nutrition and removes waste products via nutritive blood flow through the developing vascular architecture (Vaupel et al, 1989a) . In most rodent tumours, blood flow rates have been shown to decrease as tumour size increases (Jain and Ward-Hartley, 1984; Jain, 1988) . As tumours grow, the vascular volume and surface area increase more slowly than the tumour mass, diffusion distances increase and nutrients must travel further to reach all parts of the tumour. Subsequently, a point is reached when chronic or diffusion-limited hypoxia develops in cells, eventually leading to necrosis (Thomlinson and Gray, 1955) .
In vivo nuclear magnetic resonance (NMR) methods provide non-invasive indicators of tumour biochemistry and physiology and may be applied to both animal and human tumours in situ. 31p-magnetic resonance spectroscopy (MRS) has been used to provide information on tumour bioenergetic status and to monitor tumour response to therapy. Changes in 31p parameters have often been explained by changes in tumour perfusion and oxygenation (Evelhoch et al, 1986; Okunieff et al, 1986; Tozer et al, 1989; Vaupel et al, 1989b) . 2H-magnetic resonance imaging (MRI) of the freely diffusible tracer 2H20 provides an indication of tumour vascularity. The measurement of the rate of 2H signal increase in each pixel creates a map of the spatial blood flow distribution in the tumour. Previous studies using 2H-MRI on rapidly growing tumour models have demonstrated that during unperturbed growth there is a decrease in tumour blood flow (Larcombe-McDouall et al, 1991; Bumey et al, 1992) .
The majority of research on tumours and their vasculature has been performed in rapidly growing, transplanted animal tumour models. Differences in the vascular architecture and response to stimuli have been found between spontaneous and transplantable tumours (McCredie et al, 1971; Falk, 1982) , and between earlyand late-generation transplants (Steel, 1977) . Hydralazine challenge of several transplanted murine tumour models has been shown to cause a reduction in tumour blood flow (Jirtle, 1988; Kalmus et al, 1990; Horsman et al, 1992 ) and a decrease in energetic status and pH, as measured by 3'P-MRS (Okunieff et al, 1988; Dunn et al, 1989; Bhujwalla et al, 1990a) . These results are consistent with a reduction in tumour perfusion giving rise to nutrient and oxygen deprivation. This effect has been explained as follows: hydralazine acts directly on the vascular smooth muscle in vessels of normal tissues, causing vasodilation and an overall decrease in blood pressure. Tumour blood vessels, which may lack smooth muscle, basal endothelium or innervation, do not dilate in response to hydralazine. The net result is a redistribution of blood flow away from the tumour and a decrease in tumour perfusion, the so-called steal effect (Jirtle, 1988) . In addition, the high interstitial pressure Present addresses: *Aranea Consult BV, Reitscheweg SB, 5232 BX'sHertogenbosch, Holland; tGray Laboratory Cancer Research Trust, Mount Vernon Hospital, Northwood, Middlesex HA6 2JR, UK of tumours, coupled with the reduction in systemic blood pressure after hydralazine, leads to collapse of tumour vessels and a further decrease in tumour blood flow.
The objective of our experiments was twofold. The first aim was to determine whether slow-growing early-generation tumours exhibit characteristic patterns of energetics and tumour blood flow during unperturbed growth different from those seen in faster growing tumours. To this end, serial measurements, using both 3'P-MRS and 2H-MRI, were made on three early-generation transplanted murine tumours and the commonly studied, fast-growing RIF-1 mouse fibrosarcoma. The relationships between tumour energetic state, perfusion and growth rate within each line could thus be addressed.
Second, the vascular response of transplanted rodent tumour models differs in important respects from that of human tumours (Denekamp, 1992) . Primary tumours, which do not always arise at predictable times, are difficult to study and so a transplantable rodent tumour that displays a vascular response akin to a clinical tumour would be valuable. To this end, we have measured the response of the same panel of tumours to hydralazine by 31P-MRS to determine whether any differences are correlated with the rate of tumour growth and vessel development.
MATERIALS AND METHODS Induction and maintenance of tumours
Three early-generation transplanted murine tumours (kindly donated by Dr JV Moore, Paterson Institute, Manchester, UK) designated the T40 fibrosarcoma, T237 lung carcinoma and Tl 15 mammary carcinoma were used. Tumours were grown subcutaneously in the right flanks of 7-week-old male or female B6D2 (Fl ) mice (Harlan Olac) by serial passage of c. 1-to 2-mm3 pieces, irrigated in growth medium (HAM's F-10 with fetal calf serum) and implanted using a wide-bored trocar in mice under halothane (Fluothane, ZENECA) anaesthesia. The basement membrane matrix, Matrigel (Becton Dickinson), was used for the initial implantation of the T237 lung carcinoma and Ti 15 mammary carcinoma, to help establish the line. Each tumour line was reinitiated from frozen stock (i.e. pieces from an earlier generation transplant frozen in growth medium containing 10% dimethyl sulphoxide), after a maximum of five serial passages had been performed, in order to maintain stability within the tumour line.
Third-, fourth-and fifth-generation transplants of the T40 fibrosarcoma (T404 
P-MRS
To restrain the mice during the MR experiments, anaesthesia was induced with an intraperitoneal injection of a combination of fentanyl citrate (0.315 mg ml-') plus fluanisone (10 mg ml-') (Hypnorm, Janssen Pharmaceutical) and midazolam (5 mg ml ') (Hypnovel, Roche). This anaesthetic mixture has been shown to have a minimal effect on tumour blood flow (Menke and Vaupel, 1988) and 31P-MRS characteristics (Sansom and Wood, 1994) . 31P-NMR spectroscopy was performed in a 30-cm horizontal bore, 4.7-tesla superconducting magnet (Oxford Instruments) at a resonance frequency of 81 MHz. The mouse was placed on a flask containing recirculating warm water to keep the core temperature at 37°C and positioned so that the tumour hung vertically into a 1-cm two-turn surface coil. Data acquisition and processing were carried out on a Spectroscopy Imaging Systems Corporation (SISCO, Varian NMR Instruments, Palo Alto. CA, USA) spectrometer. Field homogeneity was optimized by shimming on the water signal for each tumour to a linewidth, typically, of 30-50 Hz. The position of the tumour was determined by 'H scout images. Localized 3'P spectra were acquired from cuboidal volumes of side 0.8 cm using the ISIS pulse sequence (Ordidge et al, 1986) . The voxel was selected to exclude non-tumour tissue. although in some instances overlying skin was included. Slice selection used adiabatic (sincos) inversion pulses with a gradient strength of 7.5 Gauss cm-'. Acquisition used a hard 90°pulse and a spectral width of 5 kHz with a pulse repetition time of 3 s. Total acquisition time was 16 min, and 320 transients were averaged for each free induction decay.
Spectral analysis was performed by the VARPRO time-domain non-linear least squares method, yielding the following peak parameters: areas, frequencies, linewidths and phases (van der Veen et al, 1988; van den Boogaart et al, 1995) . For each VARPRO analysis the first four data points were excluded from the fit to eliminate the influence of fast-decaying signals from immobilized phosphates that cause a baseline hump in the spectra. The data were fitted assuming contributions from PME, Pi, PDE, PCr and the three nucleoside triphosphate (NTP) resonances, and peaks were assumed to be single Lorentzians. The only biochemical and experimental prior knowledge used was that all peaks were assumed to have a phase equal to the overall zero-order phase of the spectrum. No other prior knowledge was assumed. Relative peak area ratios of the observed phosphates, for example PNTP/P. and PME/X;P, were then determined. XP was taken to be the sum of all peaks fitted by VARPRO analysis. Tumour pH was determined using the VARPRO-derived frequencies for the inorganic phosphate (P,) and czNTP resonances (Prichard et al, 1983 ).
2H-MRI
Deuterium images of 2H,O uptake were acquired at a resonance frequency of 30.7 MHz immediately after the 3'P-MRS acquisition, eliminating the need for additional anaesthetic. The mouse was positioned so that the tumour hung vertically into a 1.5-cm four-turn solenoid coil, tunable to both 'H and 2H. A 27-gauge butterfly needle was inserted into one of the tail veins for adminis-(ssfp) gradient echo sequence, with 60 ms repetition time, 10 ms echo time, 32 phase-encoding steps and 64 transients. The data were zero-filled and Fourier transformed to provide a matrix size of 64 x 64 with in-plane resolution of 0.6 mm.
After a background deuterium image, 100 jt of deuterated isotonic saline was injected intravenously as a bolus. Four deuterium images were then acquired, starting at 30, 270, 510 and 750 s after the injection, each image being obtained in 2 min. A deuterium uptake image was then calculated based on the rate of increase of signal into each pixel. A simple monoexponential model was applied to the uptake of 2H,O into each pixel as the data were not acquired until 30 s after injection, thus avoiding any fast uptake components. Results are presented as the median of all fitted values, i.e. rate constants (in units of s-') that are proportional to flow for the exponential fit.
Data analysis
For each animal at each time point, four parameters were obtained:
INTP/P, pH, PME/XP and median flow. For each animal and each parameter, a line was fitted through the values at the three time points and a slope obtained, thus using each animal as its own control. A mean slope was calculated from these fitted slopes and tested for its difference from zero using Student's t-test. A twotailed test was used for PME/XP and median flow, whereas for ,BNTP/Pi and pH a one-tailed test was allowed as these parameters are known to decline with untreated growth in a wide range of tumour models.
Histology
After the last NMR observation, tumours were excised and placed in formal saline. Sections were subsequently cut in the same orientation as for the 2H-MRI slice and stained with Ehrlich's haematoxylin and eosin, to assess differentiation status, cellularity, viable tissue and necrosis. Histological analysis consisted of a qualitative assessment of the sections, under the following headings: extensive necrosis, large central necrosis, patchy necrosis or no necrosis. To assess the correlation between the vascular pattern suggested by 2H-MRI images and the nature of the tumour vasculature and perfusion seen in the histological sections, a similar qualitative assessment of the 2H-MRI images was performed blind from the histology results, using analogous categories: extensive flow void, large central flow void, patchy flow voids or no flow voids.
Study 2: response to hydralazine 31P-MRS was performed on 2C4 RIF-1 tumours 22 days post passage (n = 5), T404 tumours 28 days post passage (ni = 7), and T1 153 tumours 45 days post passage (n = 5). For the T2374 lung carcinoma, 3'P spectra were acquired from a cohort of tumours 93 days post passage (n = 5) and these tumours were designated T2374a. After serial passage of one tumour from the T2374a cohort, spectra were acquired from a subsequent group that developed more rapidly; these were challenged 33 days post passage (n = 5) and designated T237s.
Another group, designated T2374b were initiated independently and were the same generation as the T237 4a cohort. They were challenged with hydralazine 107 days post passage (n = 4).
Localized 3'P-MRS was performed as previously described. 31P spectra were acquired in 8-min blocks from the sum of 160 transients. After acquisition of a baseline spectrum, a 5 mg kg-' bolus injection of hydralazine (Sigma) in saline was administered via a 27 G tail vein catheter, without disturbing the position of the mouse in the bore of the magnet and a further four free induction decays (FIDs) were collected. Control experiments were performed for each tumour line (n = 5), in which two baseline spectra were acquired before injection of 0.1 ml of a saline vehicle and five further spectra acquired.
Data analysis
Spectral analysis was performed by VARPRO as before, leading to estimations of the PNTP/P. ratio and tumour pH. Visual inspection of the acquired data and fitting results was aided by the Fourier transform of the MR spectra after 30 Hz line broadening.
The reproducibility of the 31P-MRS was assessed from the two pre-saline control measurements. For ,NTP/Pi, the coefficient of variation (CV) was measured in each of the 20 animals and the r.m.s. value determined. For pH, the standard deviation was measured for each of the 20 animals and the r.m.s. value determined. Tumours in which the PNTP/P, and pH responded to hydralazine are termed 'deteriorators'. We avoid the use of the term 'responder' as a deteriorating response of the spectrum is believed to imply a lack of pharmacological response of the tumour endothelium to the vasodilator. Deteriorators were defined as those tumours exhibiting a decline in both 3NTP/P, of 25% and pH of at least 0.05 units.
Results are presented in the form: mean ± standard error. Significance testing used the one-sided Student's t-test.
RESULTS
The tumour volume-doubling times for the four tumour lines are shown in Table 1 . Over the volume range studied, growth appeared exponential and there was no tendency for growth rate to slow in larger tumours to a Gompertzian pattern. In addition, all growth curves could be extrapolated back to a nominal initial implantation volume at day 0 of just over 10-2 cm3. All of the early generation transplants displayed long TD values compared with the rapidly growing RIF-1 fibrosarcoma. Because of these long TD values, there was a considerable lag period (defined as the number of days from tumour implantation to a size appropriate for MRS/I) for the Tl 153 and T2374 lines.
A sensitive index in 31P-MRS of contamination by overlying skin and muscle is PCr. In our spectra, the PCr peak, where detected, was generally small and, although small non-tumour contributions might be expected to the ISIS volumes used, in many cases these non-tumour contributions would consist mainly of air. The 3'P spectrum shown in Figure 1 was obtained from a T404 fibrosarcoma of volume 0.26 cm3. Resonances were identified for PME, Pi, PDE, PCr and y, o and fNTP. Also shown is the reconstruction after VARPRO analysis, the individual Lorentzians and the resulting residual signal showing the broad underlying resonances. A 2H uptake image from a T 1153 mammary carcinoma is shown in Figure 2 . The 2H uptake patterns were very variable from one tumour to another: some gave highest flow in the tumour edge and lower in the centre, whereas others were more heterogeneous. Table I also shows the mean and standard deviation for fNTP/Pi pH, PME/XP and median flow for each tumour line from study 1, measured at the last time point before the tumour volume For the early-generation transplants (but not for the RIF-1 fibrosarcoma), the pretreatment PNTP/P, ratio and pH were inconsistent between study 1 and study 2. Because of this variability, in the analysis of study 1 we used each animal as its own control and fitted a line through the values at the three time points to obtain a slope. A mean slope was calculated from these fitted slopes and these are shown in Table 2 with their associated P-values for progression with tumour volume for all the tumours and each individual tumour line. Analysis of the data as a whole showed a significant decrease in PNTP/P. and pH with growth, and all four tumour models individually showed a significant decrease in INTP/PI with increasing tumour volume. Tumour pH decreased significantly only in the faster growing RIF-I and T404 fibrosarcomas. In the RIF-1 tumours, median flow varied little over the course of the experiment. In all three early-generation transplants median flow tended to decrease with tumour volume, although these trends were not statistically significant. No significant progression of PME/XP with increasing volume was found for any of the tumour lines studied. Its difference from zero was tested for using the t-test and the associated P-value is given in parenthesis. The correlation coefficient rand its associated P-value in parenthesis for each possible relationship between PNTP/P, pH and median flow are also shown. slower growth rates than the RIF-1 fibrosarcoma, with both a longer volume-doubling time and lag time. The mean tumour volume was similar for each line at the times when they were challenged with hydralazine. T2374a and T2374b tumours had longer lag times than the T237s tumours that were transplanted from the T2374a cohort. For each tumour line, saline-treated tumours were studied at a similar number of days after passage to those challenged with hydralazine. In saline-treated animals, no significant 31P-MRS change was seen for any tumour line. From successive MR spectra in 20 animals before treatment, the precision of the measurements was determined: these were 22% for PNTP/P, (r.m.s. CV) and 0.1 pH units (r.m.s. s.d.) respectively. Figure 3 shows two 31P spectra acquired from a RIF-1 fibrosarcoma depicting typical changes in resonance intensity in response to 5 mg kg-' hydralazine. The energy status deteriorated after treatment, with a large increase in inorganic phosphate (P) and a reduction in NTP. Tumour pH also declined. All of the RIF-1 spectra deteriorated in response to hydralazine. The time course for this deterioration is shown in Figure 4A and B. Very different responses to hydralazine were seen for the early-generation transplants (Table 3) . For all Ti 153 and RIF-1 tumours there was a pronounced and sustained reduction in both PNTP/P, and pH. For the T404 tumours only two out of seven animals were classed as deteriorators: the mean changes in energetics and pH were not statistically significant. T2374 generation tumours were used for controls. *Indicates points significantly different from pretreatment spectra (P < 0.05) Figure 4C and D shows the changes observed in all three cohorts of T237 lung carcinomas studied. Statistical significance at 20-28 min after hydralazine challenge is shown in Table 3 . No significant changes in ONTP/P. and pH were observed for the T2374a or T2374b lung carcinoma, whereas the faster-developing T237s transplants showed a significant energetic deterioration.
DISCUSSION Study 1: unperturbed growth
The sustained median 2H20 uptake we measured in the RIF-1 tumour line during growth is consistent with the histological analysis that suggested that RIF-1 tumours are well perfused and British Journal of Cancer (1998) highly angiogenic. A low hypoxic fraction (c. 1-5%) has been previously measured in RIF-I tumours (Moulder and Rockwell, 1984; Maxwell et al, 1989 (Warren, 1979; Jain and Ward-Hartley, 1984 (Bhujwalla, 1988; Rofstad et al, 1988a) , other transplanted tumours (Ng et al, 1982; Evanochko et al, 1984; Okunieff et al, 1986; Vaupel et al, 1989b) and human tumour xenografts (Rofstad et al, 1988b) . A significant decrease of pH with tumour growth was only found for the faster growing RIF-1 and T404 tumours. A significant correlation of pH with tumour volume up to 300 mm3 has been previously reported for RIF-1 (Rofstad et al, 1988a) , and our data show that this also occurs in larger tumours.
Tumour pH was found to correlate with PNTP/P. for all four tumour lines, in agreement with previous data for RIF-1 and FsaII tumours (Rofstad et al, 1988a; Vaupel et al, 1994) . No significant progression in PME/XP, a parameter shown to increase during growth of human tumours (Griffiths et al, 1983; Negendank, 1992) , was observed for any of the tumour lines studied herein.
Previous reports suggest that the decline in bioenergetic status with tumour growth is consistent with the tumour vasculature becoming incapable of providing a nutritive blood supply to the rapidly expanding tissue (Ng et al, 1982; Evanochko et al, 1984; Okunieff et al, 1986; Bhujwalla, 1988; Rofstad et al, 1988a; Vaupel et al, 1989b) . This results in a decrease in average cellular oxygen concentrations and the development of hypoxic tissue. A general trend towards lower NTP/Pi with decreasing blood flow has also been reported in the RIF-1 using gaseous wash-out techniques (Lilly et al, 1985; Evelhoch et al, 1986; Bhujwalla et al, 1990b Tumour growth reflects a fine balance between cell division, quiescence, cell death and cell migration (Steel, 1977) . This balance may be very different in each of the four tumour lines studied herein, which had different tissues of origin, histological patterns and growth rates. Our 2H-MRI wash-in measurements are unable to distinguish between nutritive and non-nutritive blood flow, whereas 3IP-MRS reflects only nutritive blood flow. Other techniques that measure tumour blood flow by gaseous wash-out would be expected to show similar discrepancies for tumours with many large and not necessarily nutritive vessels. With growth, each tumour line showed a different pattern of large-vessel blood flow but all showed a decrease in 3NTP/Pi, indicating a decoupling between large-vessel and nutritive blood flow. 31P-MRS and 2H-MRI revealed no significant differences in energetics and blood flow between the slow-growing early-generation transplants and the fast-growing RIF-1 during unperturbed growth. Our data emphasize the complicated relationship between physiological parameters such as growth rate, TD, tumour volume, microscopic perfusion and overall tumour blood flow and also demonstrate the potential of 2H-MRI to assess tumour necrosis.
Study 2: response to hydralazine
The results presented above show that the various tumours we studied differ in their response to hydralazine. Our data for the RIF-1 fibrosarcoma are consistent with a decrease in tumour perfusion due to the steal effect, and this is in agreement with previous reports (Bhujwalla et al, 1990a) . The deterioration in mean INTP/Pi and pH observed for the T 1153 mammary carcinoma demonstrate that this early-generation transplanted tumour also showed the vascular steal effect. However, the lack of a significant decrease in mean fNTP/Pi and pH in response to hydralazine in the slowly growing T2374 lung carcinoma and T404 fibrosarcoma suggests that they did not exhibit the steal phenomenon. Such a response has not been observed previously in a transplanted rodent tumour, although a similar lack of vascular steal has been reported in primary rodent tumours, both spontaneous and radiation-induced (Field et al, 1991; Wood et al, 1992) . More recently, however, hydralazine has been shown to induce hypoxia in both transplanted and spontaneous mouse tumours, measured by 31P-MRS and invasive pO2 histography (Horsman et al, 1995; Nordsmark et al, 1996) .
The data suggest that the vasculature of the fourth-generation T2374 and T404 tumours dilated in response to hydralazine in the same way as normal vessels. However, the fifth-generation T237s tumours, which showed the steal effect, apparently had tumour vasculature that did not dilate in response to hydralazine. The fifthgeneration T237s tumours arose approximately three times more rapidly than the fourth generation T2374a tumours, which may have caused the induction of incompletely formed vessels during tumour angiogenesis. The most likely explanation is that a slower tumour growth allows the development of fully formed blood vessels that are able to respond normally. However, it is possible that the tumours lose some component of the process of angiogenic stimulation, by clonal selection, as passage number is increased. Hydralazine is believed to act directly on vascular smooth muscle, so our data suggest that the vascular smooth muscle of earlier or more slowly growing transplanted tumours is more complete than that of faster growing or later transplants. Differences in response to hydralazine between primary and transplanted tumours monitored using 31P-MRS have been 31P-MRS and 2H-MRI of murine tumour models 1759
reported. In one study, 5 mg kg-' hydralazine caused an increase in PI/XP in two transplantable tumours, the SCCVII/Ha tumour and the mammary carcinoma 16C. However, only 2 out of 12 (17%) spontaneous tumours showed a similar vascular steal with hydralazine (Wood et al, 1992) . In another report, only 4 out of I 1 (36%) primary radiation-induced murine tumours, with doubling times of 10-84 days, showed vascular steal with 5 mg kg-' hydralazine but after transplantation of one of the non-steal primary tumours into isogeneic mice, 16 out of 17 (94%) transplanted tumours, with a doubling time of 4-17 days, showed steal (Field et al, 1991) . These authors suggest that the most likely explanation for different responses to hydralazine was an effect of transplantation, causing the vasculature developing in a transplanted tumour to be different from that in primaries. Differing tumour responses to hypoxia may also have some contribution to the 31P-MRS changes observed. Our data suggest that tumour lag time and growth rate may be important determinants of response to vasodilators, as well as transplantation per se. With respect to tumour vasculature, Rowell et al ( 1990) showed that human tumour blood flow increased in response to hydralazine (0.37-2.86 mg kg-'), suggesting that human tumours contain vessels with smooth muscle and tone, perhaps as a consequence of their slow growth rate. Our data suggests that earlytransplant tumours with a slow growth rate, such as the T404 and T2374 tumours used herein, are a more appropriate model of human tumour vasculature than more rapidly growing, repeatedly transplanted tumours.
